Qiagen Reports Q3 Net Sales of $548 Million and Adjusted EPS of $0.65
Qiagen N.V. (QGEN) has released its preliminary third-quarter financial results, reporting net sales of $548 million. This figure remained consistent across both reported and constant exchange rates (CER). The company's adjusted diluted earnings per share (EPS) also held steady at $0.65 for both reported and CER metrics. These results follow recent market activity involving rumors regarding potential acquisition interest in the testing firm by EQT.
Topics: earnings report EPS M&A rumors net sales